Close

Analyst Ratings for Nektar Therapeutics (NKTR) [Sells]

NKTR Rating Summary

NKTR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NKTR
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $6.46 (+83%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 40%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/8/2022 JPMorgan Jessica Fye Downgrade Underweight
(Neutral)
N/A
(N/A)
4.42
(3.53)
-20.14% Details
4/18/2022 Goldman Sachs Chris Shibutani Downgrade Sell
(Neutral)
3.00
(N/A)
6.16
(3.53)
-42.69% Details
Like NKTR Ratings? Also take a look at BMY, TWST, LLY, PRTC

NKTR Ratings News